RSS2.0

Outbreak of skin herpes causes Minn. to shutter wresting

Wednesday, January 31, 2007

An outbreak of skin herpes has put an eight-day headlock on Minnesota high school wrestling.
From: www.denverpost.com

NEWS SECTIONS

Minneapolis - An outbreak of skin herpes has put an eight-day headlock on Minnesota high school wrestling.
From: www.currentargus.com

The Kids Are Not Alright

>From Dakota Fanning?s rape to John Cusack?s daddy issues, Sundance 2007 was all about the kiddie porn.
From: www.seattleweekly.com

American Academy of Dermatology Holds 65th Annual Meeting

The American Academy of Dermatology (Academy) will hold its 2007 Annual Meeting in Washington, DC, at the Washington Convention Center. With an anticipated attendance of more than 15,000, this meeting will feature world-renowned leaders in the field of dermatology and presentations on the latest research in the diagnosis and medical, surgical and cosmetic treatment of skin, hair and nail ...
From: www.newswise.com

Health Highlights: Jan. 30, 2007

Tuesday, January 30, 2007

Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
From: news.yahoo.com

Warner Chilcott, Foamix pact on gynaecologic foam

Warner Chilcott Company Inc. and Foamix Ltd. has announced that the two companies have signed an agreement to jointly develop gynaecologic foam.
From: www.pharmabiz.com

Obagi Launches ELASTIderm, a Significant Advance in Eye Skincare

LONG BEACH, Calif.----Obagi Medical Products, Inc. today announced the introduction of ELASTIderm Eye Cream, a novel eye-therapy product clinically proven to help the natural abilities of skin to produce insoluble elastin, decrease the number of wrinkles and increase functional elasticity of the skin.
From: biz.yahoo.com

Common beliefs on health issues are often wrong

Beliefs about health and fitness are not always rooted in fact. Popular opinion can hold sway: If you hear something often enough, you accept it as true.
From: www.ohio.com

SWEET GALE PLANTS A NEW IDEA FOR SKIN

Monday, January 29, 2007

ANATIVE Scottish plant is being hailed as a wonder treatment for people with sensitive skin.
From: www.dailyrecord.co.uk

FDA authorizes Bayer contraceptive for new indication

Berlex, a US affiliate of Bayer Schering Pharma, has said that the FDA has approved a new indication for Yaz to treat acne in women who desire an oral contraceptive for birth control.
From: www.pharmaceutical-business-review.com

New Approach Could Lower Antibiotic Requirements By 50 Times

Antibiotic doses could be reduced by up to 50 times using a new approach based on bacteriophages. Steven Hagens, previously at the University of Vienna, says that certain bacteriophages, a type of virus that infects bacteria, can boost the effectiveness of antibiotics gentamicin, gramacidin or tetracycline.
From: www.sciencedaily.com

ABOUT GLUTEN-FREE SOURCE

Details: All the products in the store are gluten-free. Fresh-baked goodies are sold three out of four weekends a month. Call or visit the Web site for specific dates. Inventory includes everything from cereal to cake mix.
From: www.ydr.com

Obagi Medical Products, Inc. Launches CLENZIderm M.D. Penetrating Acne Therapeutic System

LONG BEACH, Calif.----Obagi Medical Products, Inc. , the leader in skin health, today announced the launch of a new acne therapy - CLENZIderm M.D. Acne Therapeutic System. The new physician dispensed acne system boasts an advanced, patent-pending Soluzyl Technology that liquefies Benzoyl Peroxide on contact, resulting in greater follicular penetration and rapid lesion reduction.
From: biz.yahoo.com

R) to Treat Acne

Berlex, Inc., a U.S. affiliate of Bayer Schering Pharma, Germany, announced today that the U.S. Food and Drug Administration has approved a new indication for YAZ® to treat moderate acne vulgaris in women who desire an oral contraceptive for birth control.
From: biz.yahoo.com

FDA approves Yaz for acne treatment

Berlex Inc., a U.S. affiliate of Bayer Schering Pharma, said on Monday that the U.S. Food and Drug Administration has approved the use of the birth control medication Yaz for treating moderate acne in women.
From: news.yahoo.com

Sensitivity To Rejection Based On Appearance Bad For Mental, Physical Health

Saturday, January 27, 2007

Three new studies by a University at Buffalo psychologist offer the first known evidence that some people anxiously expect that they will be rejected by others because of their physical appearance, and that this sensitivity, if not mitigated, has serious implications for their mental and physical health.
From: www.sciencedaily.com

Celebrity skin

Friday, January 26, 2007

The skin you?re in: Not only is it your body?s largest organ, it?s also your most important accessory.
From: www.thedailypage.com

DAILY CHECKUP

Thursday, January 25, 2007

Birth control pills sometimes fail, but setting limits on how often that could happen would put newer, low-dose contraceptives off limits to women, federal health advisers said yesterday.
From: www.kentucky.com

Foamix to collaborate on vaginal foam

Wednesday, January 24, 2007

This is Foamix?s second agreement with Warner Chilcott within a month.
From: www.globes.co.il

CollaGenex Pharmaceuticals to Present at the Wachovia Securities 2007 Healthcare Conference

NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced that Colin W. Stewart, president and chief executive officer, will present at the Wachovia Securities 2007 Healthcare Conference.
From: biz.yahoo.com

Biotech Psoriasis Drugs Hit a Cost Ceiling

Tuesday, January 23, 2007

Are biotechnology companies reaching the limits of how much they can charge for their drugs? One sign of that is the sluggish sales of drugs for psoriasis.
From: www.nytimes.com

Rapid Flu Tests May Reduce Threat Of Antibiotic Resistance

New tests to rapidly detect the flu are allowing doctors to cut down on the number of hospital patients who receive antibiotics, helping soften the rapidly worsening threat of antibiotic resistance.
From: www.sciencedaily.com

International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses

According to international guidelines published in the January, 2007 issue of the Journal of the American Academy of Dermatology, Photodynamic Therapy has been recommended by a consensus group of physicians as a highly effective first- line treatment for actinic keratoses .
From: biz.yahoo.com

Myth or fact?

Ideas about health and fitness are not always rooted in fact. Popular opinion can hold sway: If you hear something often enough, you accept it as true.
From: www.kentucky.com

R-C Midday report

Monday, January 22, 2007

Genoans are seeking emergency repairs to the Town Church after a furnace failed and resulted in frozen pipes.
From: www.recordcourier.com

IPG Photonics & Reliant Technologies Introduce New Integrated Industrial Scanning System

SAN JOSE & MOUNTAIN VIEW, Calif.----IPG Photonics Corporation and Reliant Technologies, Inc. today announced the introduction of a revolutionary new industrial scanning system for high speed spot welding and drilling that can increase manufacturing throughput and end product performance.
From: biz.yahoo.com

Acne Rosacea Breakthrough Treatment

Backed with 30 years clinical research, Acne, Rosacea, Psoriasis, Eczema cause identified. (PRWeb Jan 22, 2007) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/SGFsZi1QaWdnLVN1bW0tTG92ZS1NYWduLVplcm8=
From: prweb.com

MIGENIX Announces Initiation of Rosacea Phase II Clinical Study by Partner, Cutanea Life Sciences

MIGENIX Inc. has been notified by Cutanea Life Sciences, Inc. , its development and commercialization partner for CLS001 , of the initiation of a Phase II clinical study in the treatment of rosacea.
From: biz.yahoo.com

mesalamine), The First Oral Once-Daily Mesalamine For Patients With Active, Mild To Moderate ...

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) has approved LIALDATM (mesalamine) with MMX(R) technology, indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. LIALDA is the first and only FDA-approved once-daily oral formulation of mesalamine. [click link for full article]
From: www.medicalnewstoday.com

Ask about details of Social Security

Sunday, January 21, 2007

The Arthritis Support Group of South Lake County will sponsor a Social Security question-and-answer meeting from 10 a.m. to noon Feb. 3 in the community room on the second floor of Watson Realty, 1390 N. Hancock Road, Clermont.
From: www.orlandosentinel.com

Low-cost care efforts see little interest

Saturday, January 20, 2007

The "if you build it, they will come" theory might work in the movies but not necessarily with local programs designed to help people without health insurance.
From: www.palmbeachpost.com

Robbers Get Night Deposit A Second Time

CITRUS PARK - For the second time in a month, an employee of Nine West, a shoe store, was robbed as she tried to make a night deposit at a bank on Gunn Highway.
From: westchase.tbo.com

The POWER of LIGHT

ASHLAND ? One day when Carole Sorensen was playing tennis, a sudden change of direction threw out her knee, caused cartilage and tendon damage and brought on waves of pain.
From: www.mailtribune.com

The Essentials

Friday, January 19, 2007

FASHION What if pants just fit? Proposed sizing system could make shopping easier while boosting retail sales If the pants fit, women will buy more of them, says Cricket Lee, the creator of a new fitting system that could make life easier for consumers.
From: www.redorbit.com

Kaiser to open teen clinic at Jesse Bethel

Thursday, January 18, 2007

In a first for the health maintenance giant, Kaiser Permanente Medical Center, Vallejo, will open a teen health clinic at Jesse Bethel High School to tackle teen pregnancy and obesity and provide other care, officials said Wednesday.
From: www.timesheraldonline.com

Prasco shipping generic acne treatment

Prasco Laboratories, a Cincinnati-based generic pharmaceutical company, has begun shipping a generic version of a popular acne treatement, the company announced in a press release.
From: news.enquirer.com

TM) in the Treatment of Itch in Atopic Dermatitis

Wednesday, January 17, 2007

Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced results of a Phase 2a proof-of-concept study of oral Hivenyl? in the treatment of moderate to severe itching related to atopic dermatitis which indicate that Hivenyl significantly reduces itch symptoms without signs of sedation. Hivenyl is an oral formulation ...
From: biz.yahoo.com

Reuters Canada Business Summary

TORONTO (Reuters) - CoolBrands International is in talks to sell many of its remaining assets to a division of Nestle SA , a Canadian national newspaper said on Wednesday.
From: www.globeinvestor.com

Nanotechnology Shows Promise As Next Wrinkle Fighter

The next big idea in preventing wrinkles is very, very small. Nano small. A Michigan State University chemical engineer has discovered that nanoparticles can stop thin polymer films from buckling and wrinkling, and that could well work to join the war by warding off dreaded buckles in human skin.
From: www.sciencedaily.com

FDA Clears Way for Innovative Acne Treatment Device

Tuesday, January 16, 2007

Therative today announced it has received clearance from the Food & Drug Administration to begin marketing ThermaClear, its innovative hand-held consumer medical device for the treatment of acne.
From: biz.yahoo.com

Syneron Medical to Announce Fourth Quarter and Fiscal Year 2006 Financial Results on February 15, 2007

Syneron Medical Ltd., an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announced that it will release its financial results for the fourth quarter and fiscal year of 2006 before market opening on Thursday, February 15, 2007.
From: biz.yahoo.com

Creating The Future Of Optics And Photonics: UCF Provides An Overview Of The Research Underway In The College Of Optics ...

Formed in 1986 as the Center for Research and Education in Optics and Lasers (CREOL) at the University of Central Florida, this program was the first photonic program in the United States to achieve the status of a full college headed by a dean
From: www.photonicsonline.com

After Successful Launch of Skin Care Product Line Donna Tozzi Educates on Product Line Available Online at Tozzi.biz

West Palm Beach, FL (PRWeb) January 16, 2007 -- With so many medical spas offering the same type of services and similar treatments, it can be difficult for men and women to decide which one is the absolute best.
From: news.yahoo.com

New Rosacea treatment kit

Sunday, January 14, 2007

Galderma Laboratories, L.P. has announced the availability of a new MetroGel 1% Kit for the topical treatment of the inflammatory lesions of rosacea.
From: www.news-medical.net

The Pros and Cons of Birth Control Pills

Saturday, January 13, 2007

The risks, contraindications, and benefits of the birth control pill are discussed.
From: www.bellaonline.com

mequinol 2%, tretinoin 0.01%) Topical Solution for the Treatment of ...

Friday, January 12, 2007

Currently, Solagé® Topical Solution is the only combination product approved in the United States for the treatment of solar lentigines, commonly known as "age spots," that contains two active ingredients, mequinol and tretinoin. Solar lentigines are localized, pigmented, macular lesions of the skin on the areas of the body that have been chronically exposed to sunlight and are a common ...
From: biz.yahoo.com

CoolTouch Inc. Issued Two Laser Rejuvenation Patents

CoolTouch Inc., a pioneering manufacturer of medical lasers, announced today that the United States Patent & Trademark Office has recently issued two patents which have been assigned to CoolTouch Inc.
From: biz.yahoo.com

Foamix collaborates with Warner Chilcott on acne treatment

Foamix will receive an initial payment of several hundred thousand dollars, and subsequent payments based on milestones, and royalties.
From: www.globes.co.il

Acne causes, myths and treatments

Women Hormonal fluctuations: Oil chemistry changes post-pregnancy, pre-menses and post-menopause. Stopping use of birth control pills can trigger acne.
From: www.ohio.com

Warner Chilcott and Foamix Collaborate on Foam Product for the Treatment of Acne

FAJARDO, Puerto Rico and NESS ZIONA, Israel, Jan. 3 /PRNewswire/ -- Warner Chilcott Company ( Nachrichten ), Inc. and Foamix Ltd. announced today that the two companies have signed an agreement to jointly develop an antibiotic foam for the treatment of acne.
From: www.finanznachrichten.de

Galderma USA Introduces New Kit For Rosacea Treatment

Galderma Laboratories, L.P. today announced the availability of a new MetroGel® 1% Kit for the topical treatment of the inflammatory lesions of rosacea.
From: biz.yahoo.com

The Block Doc

Acne is a skin condition caused by plugged pores, mainly on the face, neck, back and chest. It can occur at any age, but is most common during the teenage years. Close to 100 percent of people between the ages of 12 and 17 will have at least occasional acne.
From: www.blockislandtimes.com

Spotlight

COMPETACT is a new second-line, fixed-dose combination treatment for people with Type 2 diabetes failing on metformin therapy. COMPETACT combines two established oral anti-hyperglycaemic agents with confirmed efficacy (sustained glycaemic effects) and tolerability.
From: www.jcn.co.uk

R) Micro SD for Acne

SkinMedica, Inc., a specialty pharmaceutical company, today announced the launch of NeoBenz® Micro SD, the only single-dose benzoyl peroxide prescription product formulated with Microsponge® Delivery Technology for the treatment of mild to moderate acne vulgaris.
From: biz.yahoo.com